Nutex Health (NASDAQ:NUTX) Shares Gap Down - Time to Sell?

Key Points

• Nutex Health shares gapped down, opening at $204.69 versus a prior close of $213.02, before trading around $207.45.
• Analyst sentiment remains generally positive: three analysts rate the stock a Buy and one rates it Hold, producing a “Moderate Buy” consensus and a $317.50 target price. However, Zacks Research downgraded the shares from Strong Buy to Hold.
• The company exceeded quarterly earnings expectations, reporting $9.38 in EPS versus a $4.95 consensus estimate, though revenue of $210.75 million fell slightly short of forecasts.

Nutex Health Inc. (NASDAQ:NUTX - Get Free Report) gapped down prior to trading on Friday. The stock had previously closed at $213.02, but opened at $204.69. Nutex Health shares last traded at $207.45, with a volume of 13,858 shares changing hands.

Analyst Ratings Changes

Several equities analysts have recently issued reports on NUTX shares. Zacks Research cut shares of Nutex Health from a "strong-buy" rating to a "hold" rating in a research note on Tuesday. B. Riley Financial reissued a "buy" rating on shares of Nutex Health in a research note on Friday, September 4th. Lake Street Capital restated a "buy" rating and issued a $310.00 price target (up from $235.00) on shares of Nutex Health in a research report on Tuesday, August 11th. Weiss Ratings raised Nutex Health from a "hold (c+)" rating to a "buy (b-)" rating in a report on Tuesday. Finally, Wall Street Zen upgraded Nutex Health from a "hold" rating to a "buy" rating in a research report on Saturday, October 3rd. Three research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $317.50.

Nutex Health Stock Up 1.3%

The company has a quick ratio of 4.96, a current ratio of 5.00 and a debt-to-equity ratio of 0.59. The company has a market capitalization of $1.42 billion, a PE ratio of 8.16 and a beta of 0.55. The business's 50 day simple moving average is $194.13 and its 200 day simple moving average is $155.36.

Nutex Health (NASDAQ:NUTX - Get Free Report) last released its earnings results on Thursday, August 6th. The company reported $9.38 earnings per share for the quarter, topping the consensus estimate of $4.95 by $4.43. The business had revenue of $210.75 million for the quarter, compared to the consensus estimate of $215.03 million. Nutex Health had a net margin of 21.25% and a return on equity of 39.74%. As a group, analysts forecast that Nutex Health Inc. will post 27.58 EPS for the current year.

Insiders Place Their Bets

In other Nutex Health news, Director Scott Saunders sold 203 shares of the business's stock in a transaction on Friday, September 18th. The shares were sold at an average price of $214.25, for a total transaction of $43,492.75. Following the sale, the director directly owned 400 shares of the company's stock, valued at $85,700. The trade was a 33.67% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 44.68% of the company's stock.

Institutional Trading of Nutex Health

Several hedge funds and other institutional investors have recently modified their holdings of the business. WINTON GROUP Ltd purchased a new stake in Nutex Health in the 2nd quarter worth about $237,000. Allworth Financial LP grew its stake in Nutex Health by 41.0% during the 2nd quarter. Allworth Financial LP now owns 203 shares of the company's stock valued at $35,000 after acquiring an additional 59 shares in the last quarter. Arizona State Retirement System purchased a new position in Nutex Health during the 2nd quarter valued at about $230,000. Corient Private Wealth LP increased its holdings in shares of Nutex Health by 5.1% in the 2nd quarter. Corient Private Wealth LP now owns 6,684 shares of the company's stock valued at $1,142,000 after purchasing an additional 325 shares during the period. Finally, Amundi acquired a new position in shares of Nutex Health in the 2nd quarter valued at about $378,000. Institutional investors and hedge funds own 5.32% of the company's stock.

Nutex Health Company Profile

Nutex Health Inc is a physician-led healthcare company that operates an integrated network of micro hospitals, specialty hospitals and other healthcare facilities. Its care-delivery business provides emergency, inpatient and outpatient services designed to offer localized access to hospital care, particularly in communities that may be underserved by traditional hospital systems.

The company also operates a population health management business. Through affiliated physician networks and independent physician associations, Nutex Health provides services such as care coordination, utilization management and support for value-based care arrangements.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.